Bullous Skin Manifestations of Infection: A Case Series.

J Investig Med High Impact Case Rep

University of Nevada, Las Vegas Campus, Las Vegas, NV, USA.

Published: September 2017

Bullous skin lesions are uncommon in children. While it is well known that infections are associated with papular skin manifestations, bullous skin lesions are not commonly reported. is a very common bacterial pathogen causing respiratory tract infection in children and adults. We report 2 children with serology-confirmed infection who were hospitalized for blistering skin lesions. Both of our patients responded well to corticosteroids and one of them required intravenous immunoglobulin. The aim of this case report is to raise awareness that infection can present with bullous skin lesions, and to briefly review the pathophysiology, diagnosis, and management of the skin manifestation of infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593211PMC
http://dx.doi.org/10.1177/2324709617727759DOI Listing

Publication Analysis

Top Keywords

bullous skin
16
skin lesions
16
skin manifestations
8
skin
6
infection
5
bullous
4
manifestations infection
4
infection case
4
case series
4
series bullous
4

Similar Publications

IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid.

Front Immunol

December 2024

Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Introduction: Bullous pemphigoid (BP) and prurigo nodularis (PN) are chronic pruritic skin diseases that severely impact patients' quality of life. Despite the widespread attention these two diseases have garnered within the dermatological field, the specific pathogenesis, particularly the molecular mechanisms underlying the pruritus, remains largely unclear. Limited clinical sequencing studies focusing on BP and PN have hindered the identification of pathological mechanisms and the exploration of effective treatment strategies.

View Article and Find Full Text PDF

Bullous pemphigoid (BP) is the most prevalent autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and manifests with pruritus and localized or, most commonly, generalized bullous lesions. Numerous studies have established the association between BP and oral antidiabetic agents, particularly dipeptidyl peptidase 4 (DPP4) inhibitors, diuretics, and certain antibiotics, notably levofloxacin and cephalexin.

View Article and Find Full Text PDF

Bullous pemphigoid (BP) is a rare autoimmune blistering disease characterised by autoantibodies against basal skin membrane antigens. Although the condition's aetiology remains unclear, recent cases have raised suspicions of an association with immunisation. In this study, we present a case of BP onset in a four-month-old infant following routine vaccination.

View Article and Find Full Text PDF

Macrophages in inflammatory skin diseases and skin tumors.

Front Immunol

December 2024

Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Article Synopsis
  • - Macrophages are key immune cells that play diverse roles in the body, especially in the skin, which is the largest immune organ and is crucial for studying various skin-related conditions.
  • - This review focuses on recent findings about macrophages in inflammatory skin diseases like atopic dermatitis and psoriasis, as well as skin tumors such as melanoma and cutaneous T-cell lymphoma.
  • - The goal is to enhance understanding of how macrophages contribute to these diseases and explore potential new treatments targeting them.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!